摘要
目的系统评价内观认知疗法对我国精神分裂症患者临床症状的治疗效果。方法检索PubMed、Embase、Cochrane、Medline、Web of Science、CBM、CNKI、VIP、万方数据、TWS。检索内观认知疗法治疗精神分裂症患者阳性与阴性症状量表(PANSS)评分影响的随机对照试验(RCT),采用RevMan5.3软件进行Meta分析。结果共纳人9项RCT,试验组389例,对照组393例。结果显示,内观认知疗法能够降低精神分裂症患者的PANSS总分及阳性症状、阴性症状、一般精神病理症状各因子分(P<0.05)。结论内观认知疗法对恢复期精神分症患者临床症状改善有效,对一般精神病理症状和阴性症状疗效尤为显著。
Objectives To systematically evaluate the efficacy of Naikan cognitive therapy in PANSS patients with schizophrenia in China. Methods Databases including PubMed、Embase、Cochrane、Medline、 Web of science、CBM、CNKI、VIP、WanFang Data、TWS. We searched databases to collect PANSS related randomized controlled trials of patients with schizophrenia treated used Naikan cognitive therapy. RevMan 5.3 software was used for meta-analysis. Results A total of 9 randomized controlled trials were included, 389 cases of experimental group and 393 cases of control group.The results showed that the total PANSS score, positive symptoms score, negative symptoms score and general psychopathological symptoms score of schizophrenia patients could be reduced by Naikan cognitive therapy (P <0.05). Conclusions To some extent, Naikan cognitive therapy is helpful to improve the clinical symptoms of schizophrenia, especially general psychopathological symptoms and negative symptoms.
作者
毛英莹
吕雨梅
王伟梁
何宇迪
周郁秋
Mao Yingying;Lyu Yumei;Wang Weiliang;He Yudi;Zhou Yuqiu(Nursing College,Daqing District of Harbin Medical University,Daqing 163319 China)
出处
《神经疾病与精神卫生》
2019年第4期343-347,共5页
Journal of Neuroscience and Mental Health
基金
国家自然科学基金面上项目(71673070).
作者简介
通信作者:吕雨梅,Email:lvyumeihua@163.com.
